HK1022908A1 - Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase - Google Patents

Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase

Info

Publication number
HK1022908A1
HK1022908A1 HK00101973A HK00101973A HK1022908A1 HK 1022908 A1 HK1022908 A1 HK 1022908A1 HK 00101973 A HK00101973 A HK 00101973A HK 00101973 A HK00101973 A HK 00101973A HK 1022908 A1 HK1022908 A1 HK 1022908A1
Authority
HK
Hong Kong
Prior art keywords
cyclohepta
benzo
inhibition
protein transferase
pyridine derivatives
Prior art date
Application number
HK00101973A
Other languages
English (en)
Inventor
Ronald J Doll
Joseph M Kelly
Alan K Mallams
F George Njoroge
Stacy W Remiszewski
Arthur G Taveras
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK1022908A1 publication Critical patent/HK1022908A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK00101973A 1997-06-17 2000-03-31 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase HK1022908A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87705797A 1997-06-17 1997-06-17
PCT/US1998/011500 WO1998057959A1 (en) 1997-06-17 1998-06-15 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase

Publications (1)

Publication Number Publication Date
HK1022908A1 true HK1022908A1 (en) 2000-08-25

Family

ID=25369159

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00101973A HK1022908A1 (en) 1997-06-17 2000-03-31 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase

Country Status (30)

Country Link
EP (2) EP0988300B1 (zh)
JP (1) JP2002504148A (zh)
KR (1) KR100588799B1 (zh)
CN (1) CN1131228C (zh)
AR (1) AR016074A1 (zh)
AT (1) ATE222905T1 (zh)
AU (1) AU753863B2 (zh)
BR (1) BR9811470A (zh)
CA (1) CA2294347C (zh)
CO (1) CO4940455A1 (zh)
CZ (1) CZ297450B6 (zh)
DE (1) DE69807477T2 (zh)
DK (1) DK0988300T3 (zh)
ES (1) ES2178224T3 (zh)
HK (1) HK1022908A1 (zh)
HU (1) HUP0003046A3 (zh)
ID (1) ID30349A (zh)
IL (2) IL133449A0 (zh)
MY (1) MY117925A (zh)
NO (1) NO318938B1 (zh)
NZ (1) NZ501618A (zh)
PE (1) PE83799A1 (zh)
PL (1) PL191866B1 (zh)
PT (1) PT988300E (zh)
RU (1) RU2220139C2 (zh)
SK (1) SK283820B6 (zh)
TR (2) TR200003580T2 (zh)
TW (1) TW544451B (zh)
WO (1) WO1998057959A1 (zh)
ZA (1) ZA985210B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9911869A (pt) 1998-07-06 2001-03-27 Janssen Pharmaceutica Nv Inibidores da transferase da proteìna farnesil para o tratamento das artropatias
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
PE20020635A1 (es) * 2000-11-29 2002-07-11 Schering Corp Compuestos triciclicos como inhibidores de la farnesil transferasa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them

Also Published As

Publication number Publication date
RU2220139C2 (ru) 2003-12-27
DK0988300T3 (da) 2002-11-25
IL133449A (en) 2006-12-10
SK283820B6 (sk) 2004-02-03
NO318938B1 (no) 2005-05-30
PT988300E (pt) 2002-12-31
NO996236L (no) 2000-02-01
HUP0003046A2 (hu) 2001-06-28
TR200003580T2 (tr) 2002-10-21
AR016074A1 (es) 2001-06-20
CO4940455A1 (es) 2000-07-24
ES2178224T3 (es) 2002-12-16
ATE222905T1 (de) 2002-09-15
CZ447199A3 (cs) 2000-06-14
DE69807477T2 (de) 2003-02-27
PL191866B1 (pl) 2006-07-31
CN1131228C (zh) 2003-12-17
WO1998057959A1 (en) 1998-12-23
JP2002504148A (ja) 2002-02-05
EP1156046A1 (en) 2001-11-21
KR20010013948A (ko) 2001-02-26
NZ501618A (en) 2001-10-26
CA2294347C (en) 2008-01-29
CZ297450B6 (cs) 2006-12-13
TR200000114T2 (tr) 2000-08-21
AU753863B2 (en) 2002-10-31
CA2294347A1 (en) 1998-12-23
TW544451B (en) 2003-08-01
DE69807477D1 (de) 2002-10-02
EP0988300B1 (en) 2002-08-28
HUP0003046A3 (en) 2002-11-28
ID30349A (id) 2001-11-22
NO996236D0 (no) 1999-12-16
EP0988300A1 (en) 2000-03-29
ZA985210B (en) 1999-01-07
SK182499A3 (en) 2000-09-12
MY117925A (en) 2004-08-30
PE83799A1 (es) 1999-10-23
CN1267294A (zh) 2000-09-20
BR9811470A (pt) 2000-09-19
PL337481A1 (en) 2000-08-28
KR100588799B1 (ko) 2006-06-13
IL133449A0 (en) 2001-04-30
AU8058298A (en) 1999-01-04

Similar Documents

Publication Publication Date Title
ZA969087B (en) Farnesyl transferase inhibiting 2-quinolone derivatives.
IL123155A0 (en) 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors
HK1012188A1 (en) Farnesyl protein transferase inhibiting (imidazol-5-yl) methyl-2-quinolinone derivatives
GR3036346T3 (en) BENZO[g]QUINOLINE DERIVATIVES
HK1020344A1 (en) Pde iv inhibiting 2-cyanoiminoimidazole derivatives
ZA978809B (en) PDE IV inhibiting 2-cyanoiminoimidazole derivatives
PL337712A1 (en) Polymorphous form of 8-chloro-6, 11-dihydro-11-94-piperydilene) -5h-benzo[5,6]cyclohepta [1,2-b] pyridine
ZA985211B (en) Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors
NO20005485D0 (no) Orale preparater inneholdende 8-klor-6,11-dihydro-11-(4- piperyliden)-5H-benzo-[5,6]syklohepta[1,2-b]pyridin
HK1033579A1 (en) Pde iv inhibiting pyridine derivatives
HUP0003046A3 (en) Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase
IL143408A0 (en) Tricyclic farnesyl protein transferase inhibitors
IL133393A0 (en) Novel tricyclic sulfonamide inhibitors of farnesyl-protein transferase
HUP0004806A3 (en) Benzo[5,6]cyclohepta[1,2-b]pyridine derivatives useful for inhibition of farnesyl protein transferase and medicaments containing the compounds
HUP0002863A3 (en) Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase and pharmaceutical compositions containing them
SI0839136T1 (en) BENZO(g)QUINOLINE DERIVATIVES
ZA965748B (en) Benzo(g)quinoline derivatives.
IL133446A0 (en) Novel phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110615